Summary
The influence of the calcium antagonist nisoldipine on collagen-induced platelet aggregation and platelet thromboxane formation was studied ex vivo in healthy male volunteers in a double-blind, placebo-controlled crossover design. Measurements of general haemodynamics, immunoreactive 6-oxo-prostaglandin F1α and thromboxane B2 ex vivo and collagen-induced (0.6 and 2.5 µg/ml) platelet aggregation were performed immediately before (time 0), 0.5 h, 1 h and 2 h after ingestion of 10 mg nisoldipine or an identical placebo tablet. Compared with the control response at time 0, administration of nisoldipine resulted in a significant inhibition of both low-collagen-induced platelet aggregation and formation of immunoreactive thromboxane B2 at time 0.5 h. There were no changes in heart rate or systolic blood pressure but a significant decrease in diastolic blood pressure by nisoldipine at 1 h. No such change was obtained with placebo and there were also no alterations with nisoldipine in platelet aggregation and thromboxane formation after stimulation by high-dose collagen at this or any other time of the study. The data demonstrate a platelet-in-hibitory potential of nisoldipine in healthy men which is probably related to an increased resistance of the platelet membrane against foreign stimuli.
Similar content being viewed by others
Abbreviations
- EDTA:
-
Äthylendiamintetraessigsäure
- PRP:
-
Plättchenreiches Plasma
- 6-oxo-PGF1α :
-
6-oxo-Prostaglandin-F1α
- TX:
-
Thromboxan
Literatur
Billah MM, Lapetina EG, Cuatrecasas P (1980) Phospholipase A2 and phospholipase C activities of platelets. J Biol Chem 255:10227–10231
Charo IF, Feinman RD, Detwiler TC (1977) Interrelations of platelet aggregation and secretion. J Clin Invest 60:866–873
Darius H, Ahland B, Rücker W, Klaus W, Peskar BA, Schrör K (1984) The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation and eicosanoid formation in vitro — inhibition of 12-HPETE biosynthesis. J Cardiovasc Pharmacol 6:115–121
Davi G, Novo S, Fiore M, Foderá A, Mattina A, Mazzola A, Szano A (1982) Effects by nifedipine on thromboxane synthesis in vitro and in vivo. Thromb Res 28:837–843
Hampton JR, Harrison MJG, Honour AJ, Mitchell JRA (1967) Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res 1:101–107
Johnson GJ, Francis GS (1981) Calcium channel antagonists inhibit epinephrine potentiation of thromboxane A2 induced human platelet aggregation. Clin Res 29:751A
Johnsson H (1981) Effects by nifedipine on platelet function in vitro and in vivo. Thromb Res 21:523–528
Kazda S, Garthoff B, Meyer H, Schloßmann K, Stoepel K, Towart R, Vater W, Wehinger E (1980) Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine-dicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforsch 30:2144–2162
Latta G, Verheggen R, Rücker W, Schrör K (1983) Inhibition of human platelet aggregation and thromboxane formation by calcium antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 324 [Suppl]: R-49
MacIntyre DE, Rink TJ (1982) The role of platelet membrane potential in the initiation of platelet aggregation. Thromb Haemostas 47:22–26
Marcus AJ (1978) The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lipid Res 19:793–825
Muhrer EH, Stewart GJ, Davenport K, Sioho E (1981) Effect of three calcium antagonists on platelet secretion and metabolism. Biochem Pharmacol 30:523–530
Okamatsu S, Peck RC, Lefer AM (1981) Effects of calcium channel blockers on arachidonate-induced sudden death in rabbits. Proc Soc Exp Biol Med 166:551–555
Peskar BA, Anhut H, Kröner EE, Peskar BM (1979) Development, specificity and some applications of radioimmunoassays for prostaglandins and related compounds. In: Tillement JP (Ed) Advances in Pharmacology and Therapeutics, Vol. 7, Biochemical Clinical Pharmacology, Pergamon Press, Oxford-New York, pp 275–286
Schmunk GA, Lefer AM (1982) Antiaggregatory actions of calcium channel blockers in cat platelets. Res Comm Chem Pathol Pharmacol 35:179–187
Author information
Authors and Affiliations
Additional information
Ein Teil der Ergebnisse wurde auf dem II. Internationalen Prostaglandin Symposion, Nürnberg-Fürth, 9.–11. Mai 1984 mitgeteilt
Rights and permissions
About this article
Cite this article
Schrör, K., Latta, G., Darius, H. et al. Hemmung der Plättchenaggregation und Thromboxanbildung durch den Calcium-Antagonisten Nisoldipin nach einer oralen Einmaldosis von 10 mg. Klin Wochenschr 63, 16–19 (1985). https://doi.org/10.1007/BF01537481
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01537481